Innovative ovarian cancer research newly supported by R37 MERIT Award
One of the most impactful advancements during the past decade in treating ovarian cancer is…
Browsing: ovarian cancer
ESMO 2021: Maintenance Olaparib in Ovarian Cancer
Highlights on maintenance olaparib in ovarian cancer previously treated with PARPi
ESMO 2021: FRAME Trial
Highlights on a phase I of dual RAF/MEK inhibitor + FAK inhibitor in ovarian cancer…
Exploring the microscopic defects causing ovarian cancer to spread
Ovarian cancer devastates more than 20,000 women in the U.S. every year, due in part…
Ovarian cancer: Potential therapeutic target identified
A gene called DOT1L appears to play a role in progression and severity of ovarian…
Team identifies molecular mechanisms and biomarkers in ovarian cancer
UT Southwestern faculty (USA) have discovered what appears to be an Achilles’ heel in ovarian…
Increasing the accuracy of early ovarian cancer detection
A test being developed in Queensland could help to reduce the high mortality rate from…
Could powerful ovarian cancer treatments benefit more patients?
WEHI researchers have made a discovery that could help more Australian women with ovarian cancer gain access…
New organ-on-a-chip finds crucial interaction between blood, ovarian cancer tumours
In the evolving field of cancer biology and treatment, innovations in organ-on-a-chip microdevices allow researchers…
AI-Based study designed to identify ovarian cancer risk in women
The University of South Australia will lead a world-first study, using artificial intelligence, to map…